Changes in the practice of percutaneous coronary intervention following the introduction of drug-eluting stents.

被引：0
|
作者：
Shabari, FR [1 ]
Sadoughi, A [1 ]
Hashemi, V [1 ]
Pourdehmobed, K [1 ]
Farouque, HMO [1 ]
Ikeno, F [1 ]
Lyons, J [1 ]
Emami, S [1 ]
Kaneda, H [1 ]
Young, AC [1 ]
Rezaee, M [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：221E / 221E
页数：1
相关论文
共 50 条
  • [21] Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention
    Chu, WW
    Kuchulakanti, PK
    Torguson, R
    Wang, B
    Clavijo, LC
    Suddath, WO
    Pichard, AD
    Satler, LF
    Kent, KM
    Waksman, R
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (04) : 595 - 599
  • [22] Drug-Eluting Stents in Percutaneous Coronary Intervention A Benefit-Risk Assessment
    Byrne, Robert A.
    Sarafoff, Nikolaus
    Kastrati, Adnan
    Schoemig, Albert
    DRUG SAFETY, 2009, 32 (09) : 749 - 770
  • [23] The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
    van Domburg, RT
    Lemos, PA
    Takkenberg, JJM
    Liu, TKK
    van Herwerden, LA
    Arampatzis, CA
    Smits, PC
    Daemen, J
    Venema, AC
    Serruys, PW
    Bogers, AJJC
    EUROPEAN HEART JOURNAL, 2005, 26 (07) : 675 - 681
  • [24] Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents
    Makkar, Kathy
    Wilensky, Robert L.
    Julien, Maureen Burke
    Herrmann, Howard C.
    Spinler, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1204 - 1207
  • [25] Clinical outcomes following percutaneous coronary intervention before and after introduction of drug-eluting stent
    Naito R.
    Miyauchi K.
    Ogita M.
    Tsuboi S.
    Konishi H.
    Dohi T.
    Kasai T.
    Tamura H.
    Okazaki S.
    Isoda K.
    Daida H.
    Cardiovascular Intervention and Therapeutics, 2015, 30 (4) : 338 - 346
  • [26] Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent
    Doostzadeh, Julie
    Clark, Lee N.
    Bezenek, Susan
    Pierson, Wesley
    Sood, Poornima R.
    Sudhir, Krishnankutty
    CORONARY ARTERY DISEASE, 2010, 21 (01) : 46 - 56
  • [27] Drug-eluting polymer coatings for cardiac stents.
    Calistri-Yeh, M
    Rosebrough, S
    Chamberlain, A
    Donish, W
    Whitbourne, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U471 - U471
  • [28] Duration of Clopidogrel Therapy with Drug-Eluting Stents.
    Okura, Hiroyuki
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05): : 488 - 488
  • [29] Improved clinical outcome with biodegradable polymer drug-eluting stents compared to durable polymer drug-eluting stents for primary percutaneous coronary intervention
    Andriyati, Ratna
    Firman, Doni
    Kurniawati, Yovi
    Alkatiri, Amir Aziz
    Pranata, Raymond
    Muliawan, Hary Sakti
    Rossimarina, Vienna
    Soerianata, Sunarya
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1152) : 638 - 643
  • [30] The changing profile of patients and lesions undergoing percutaneous coronary intervention: Before and after the introduction of drug-eluting stents
    Sheikh, AM
    Ghazzal, Z
    Douglas, JS
    Liberman, HA
    Vaccarino, V
    Veledar, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 5B - 5B
12345